Abstract
DNA analysis of the Ig genes has been utilized to delineate the stages of differentiation of normal and malignant B-lineage cells, since the mechanisms involved in V(D)J recombination, somatic hypermutations, and class switch are developmentally regulated. Somatic mutations which result in amino acid substitutions are observed frequently in the Ig variable region genes in multiple myeloma (MM), but there is no intraclonal variation. This fact suggests that the target cell of malignant transformation in MM is a B-lineage cell which already has undergone antigenic selection. This B-lineage cell probably corresponds to a pre-plasma cell or a plasma cell rather than a memory B cell. Tumour cells which share an identical third-complementarity-determining-region (CDR3) sequence with the myeloma cells can be detected from the various fractions representing different stages of B-cell differentiation, such as CD34+, CD20+CD10+, CD20+CD21+, CD20+CD19- cells from the peripheral blood. Thus, the tumour cells in MM are composed of immunophenotypically heterogeneous subpopulations at various stages of differentiation, similar to normal B-lineage cells. These results imply that there is an analogous developmental pathway between the normal B-...Continue Reading
References
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C M BaumB Peault
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D W Bahler, R Levy
Jan 1, 1992·Annual Review of Immunology·D G SchatzM S Schlissel
Dec 20, 1991·Cell·C BerekM Apel
Aug 16, 1990·The New England Journal of Medicine·M YamadaG Rovera
Mar 8, 1990·The New England Journal of Medicine·J EpsteinX Y He
Mar 1, 1990·Clinical and Experimental Immunology·N KiyokawaJ I Hata
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Mar 8, 1990·The New England Journal of Medicine·R J Buchsbaum, R S Schwartz
Nov 1, 1989·The Journal of Experimental Medicine·A NeriR Dalla-Favera
Jul 1, 1988·The Journal of Experimental Medicine·J BirdJ Sklar
Aug 3, 1986·Nature·R KleinfieldM Weigert
Jan 1, 1987·Acta Haematologica·M BoccadoroM Tribalto
Apr 1, 1987·Immunological Reviews·C Berek, C Milstein
Jan 1, 1994·Stem Cells·S FruehaufW Hunstein
May 1, 1994·British Journal of Haematology·M H BakkusK Thielemans
May 1, 1994·British Journal of Haematology·O ShpilbergB Ramot
Aug 1, 1994·British Journal of Haematology·M TakishitaS Saito
Jan 1, 1994·Annual Review of Immunology·I C MacLennan
Sep 1, 1993·The Journal of Experimental Medicine·D BilladeauB Van Ness
Sep 1, 1993·The Journal of Experimental Medicine·P CorradiniA Pileri
Jan 1, 1993·Annual Review of Immunology·W HarrimanM Wabl
Jan 1, 1993·Annual Review of Immunology·D Gray